Monoclonal (me) Alloantibodies. All studies were done with the mc Ly-5 alloantibodies (ascites plus serum) anti-Ly-5.1 (clone 104-2) and anti-Ly-5.2 (clone A-20) (12) . Both are yz,~¢ and critically distinguish the B6 and B6-Ly-5.2 congenic strains. Both react with adherent accessory, T, and B cells in protein A binding and direct immunofiuorescence assays. The Lyb-2.1 me antibody was the same as used in previous studies (1 3) .
Cell Preparations
T CELLS. These were prepared by nylon selection of spleen cells (13) . T-DEPLETED SPLEEN CELLS. T cells were eliminated by exposure of spleen cells first to mca-Thy-1.2 (1:100) plus rabbit serum complement (C) and then to [mc-a-Lyt-1.2 (1:25) and mca-Lyt-2.2 (1:25)] plus C as described (3) . The two treatments were required to eliminate residual T cells effectively (3) .
M4~. Splenic adherent cells treated with mc-a-Thy-l.2 plus C and irradiated with 1,500 rad were used as MS (3) .
Mdp-DEPLETEO CELLS. Spleen cells (~18 × 107) were passed over a Sephadex G-10 column (bed volume, 30 ml; Pharmacia Fine Chemicals, Dip. of Pharmacia Inc., Piscataway, N J) and eluted with 25 ml of RPMI 1640 (Grand Island Biological Co., Grand Island, NY) containing 20% fetal bovine serum (FBS) and antibiotics (14) , and the procedure was repeated. This treatment reduced the a-SRBC PFC response by >95% and esterase-positive cells from 5-9% to <0.5%, without significant disproportion ofT and B cells, determined by immunofluorescence with fluorescein-conjugated mc-a-Thy-1.2 and rabbit a-mouse immunoglobulin.
B CELLS. M~-depleted spleen cells were treated as above for elimination ofT cells.
Mishell-Dutton Culture. Spleen cells, untreated or as combinations of fractionated cell populations (see above), were cultured in RPMI 1640 supplemented with 10% FBS, L-glutamine (2 mM), 2-mercaptoethanol (5 X 10 -° M), sodium pyruvate (1 mM), streptomycin (100 #g/ml), penicillin (100 U/ml), and Hepes buffer (10 raM) in 16-ram flat-bottomed Linbro plates (Linbro Chemical Co., Hamden, CT) with SRBC (5 X 106), TNP-BA (1:1,000 of stock), TNP-LPS (1 /~g/ml), or TNP-F (1 ng/ml), unless otherwise stated, at 37°C in a humidified atmosphere of 10% CO2 and 90% air without rocking. Cultures were fed daily as in (2) .
PFC Assay. PFC counts were determined on day 5 for a-SRBC, and on day 4 for a-TNP responses to T-independent (TI) antigens, by the slide version (15) of Jerne plaque assay. Lightly conjugated TNP-SRBC was prepared as described (16) . Results were expressed as mean PFC per culture ---SEM or as a percentage of the standard control response [100 (PFC experiment)/(PFC control)].
Preparation of Factors
MIXED LYMPHOCYTE CULTURE SUPERNATANT (MLC-SN), 5 X 10 6 B6 spleen cells were stimulated with 5 × 106 irradiated DBA/2 spleen cells (2,000 rad) in 1 ml of Mishell-Dutton medium (MDM) in a Linbro well. 24 h later, the SN was centrifuged, filtrated, and stored at -20°C. Higher concentrations of this preparation had significant M~-substituting activity as previously reported (3).
M~-SN. 2 × 106 P388D.1 cells, kindly provided by Dr. Peter Ralph of the Sloan-Kettering Institute for Cancer Research, were cultured in 1 ml of MDM with 10 ng/ml phorbol myristate acetate (Sigma Chemical Co., St. Louis, MO) in a Linbro well for 4 d. The cell-free SN was dialyzed against 100 vol of RPMI 1640, filtrated, and stored at -20°C. This preparation, at concentrations used in this study (0.1-4%), had negligible capacity to replace T cell activity in supporting a-SRBC PFC generation from T-depleted cells. (Fig. 1 ). Spleen cells from B6 (Ly-5.1) and congenic B6-Ly-5.2 mice were cultured with SRBC in the presence of various concentrations of mc-a-Ly-5.1 for 5 d. Fig. 1 shows that mc-a-Ly-5.1 antibody at concentrations of from 1:100 to 1:1,600 inhibited a-SRBC PFC generation from B6 cells by 75-83%. Specificity for Ly-5 is shown by the fact that same antibody caused no significant reduction in the responses from congenic B6-Ly- Target Cells Affected by (Tables I and II) . Ly all hematopoietic cell types. To determine whether T and non-T cells are involved in the reduction of a-SRBC PFC generation by Ly-5 antibody (above), spleen cells from B6 and B6-Ly-5.2 mice were fractionated into T and T-depleted populations, combined in all four possible combinations, and cultured with or without mc-a-Ly-5.1 at concentrations of 1:400 and 1:800. As shown in Table I , a-SRBC PFC generation was reduced only when the T-depleted population (B and accessory cells) was Ly-5.1 ; the Ly-5 type of the T population was irrelevant. This implies that the action of Ly-5 antibody in reducing PFC generation is on B or accessory cells rather than T cells. A similar fourfold combination was then used to determine whether the PFC-reducing effect of Ly-5 antibody is due to its reaction with B cells or with Mq~. The two cell donors, as before, were B6 and B6-Ly-5.2, the cell populations in this case being M~ depleted and M~ selected. Table II shows that PFC responses were reduced only when the phenotype of the M@depleted cells was Ly-5.1, corresponding to the antibody; the phenotype of the M~ was irrelevant. This implies that the cells mostly concerned in PFC reduction by Ly-5 antibody are B cells. (Table III, Fig. 2 ). To test whether the PFC inhibitory property of Ly-5 antibody might be due to indirect or direct activation of suppressor cells, two sets of experiments were performed. The first experiments tested the possibility that the interaction of B cells with Ly-5 antibody induces Lyt-2 ÷ suppressor cells. Nylon-selected splenic T cells were treated with Lyt-2 antibody and C under predetermined optimal conditions for elimination of Lyt-2 ÷ cells (removing the Lyt-123 and Lyt-23 cell sets), and were then added to T-depleted spleen cells. This pre-elimination of Lyt-2 + cells did not affect the PFC-reducing capacity of Ly-5 antibody (Table III) .
Results

Inhibition of Generation of a-SRBC PFC by mc
Evidence against Suppression or a Shift of Kinetics
In the second set of experiments, unselected spleen cells from B6 and B6-Ly-5.2 donors were combined in serial proportions and cultured with mc-a-Ly-5.1 (1:800) or In the other experiments it was observed that the peak time of PFC generation was same in the presence or absence of Ly-5 antibody, signifying that the lower peak in the presence of antibody is not due to delay or acceleration in the rate of PFC generation.
Effect of Ly-5 Antibody on PFC Generation to TI Antigens of Types 1 and 2 (Table IV and Fig. 3) . Table IV shows that Ly-5 antibody, at concentrations causing maximal reduction of a-SRBC PFC generation, did not demonstrably inhibit generation of PFC to the two TI-1 antigens tested, TNP-BA and TNP-LPS. This was equally true for antigen concentrations ranging from 0.1 to 100 #g/ml for TNP-LPS and for 10 -a to 10 -6 dilutions of stock for TNP-BA (data not shown). The prototype TI-2 antigen tested, TNP-F, gave a quite different result. This mca-Ly-5.1 antibody in concentrations >1:1,600 gave strong Ly-5-specific inhibition of a-TNP PFC (Fig. 3, panel A) , and this inhibition was evident with TNP-F antigen concentrations ranging from 102 to 10 -4/lg/ml (panel B). The degree of inhibition of a-TNP PFC was similar to that of a-SRBC PFC, roughly 60-80% reduction. DBA/2 was included in these studies as a high responder to the antigens used. (Fig. 4 ). Fig. 4 shows that Ly-5 antibody added >24 h after initiation of culture is relatively ineffective in reducing PFC generation to SRBC and TNP-F, and antibody addition delayed for >48 h has virtually no effect. In view of the persistent expression of Ly-5 on mature B cells, these data imply that Ly-5 is involved in an early phase of B cell activation that is complete within 2 d. (Table  V) . The purpose of this test was to find whether Ly-5 antibody might suppress PFC generation by direct effect upon B cells rather than by obstructing function of the Ly-5 molecule. In the case of the Lyb-7 system, antibody similarly suppresses PFC generation to the TI-2 antigen TNP-F, and this suppression affects Lyb-7 heterozygotes as well as homozygotes, which would allow the former interpretation (17) . This is not so with Ly-5. Thus mc-a-Ly-5.1 antibody caused no reduction in PFC generation from Ly-5 heterozygous cells with TNP-F or SRBC (Table V) . (Table  VI and Figs. 5, 6, and 7) . Generation of PFC to SRBC and to TNP-F depends on
Time of Action of Ly-5 Antibody
Generation of PFC from Ly-5 Heterozygous Cells in the Presence of Ly-5 Antibody
Effect of Ly-5 Antibody on a-SRBC PFC Generation Assisted by T and Mob Factors
both T cells and M(h (18-21). The question arises whether Ly-5 is involved in the B cell response to T or M(h signals. The rationale of the following experiments is that if Ly-5 is concerned in the interaction of B cells with T cells or M(h, then PFC reduction by Ly-5 antibody should be competitively overcome by T or Mq~ helper factors.
RESPONSES OF T-DEPLETED CELLS ASSISTED BY MLC-SN. Table VI illustrates that Ly-5 antibody caused maximal a-SRBC PFC reduction in concentrations of MLC-SN as high as 40%. Even in 80% MLC-SN, reduction was only slightly less, and this small effect could well be due to minor contamination of MLC-SN with M(h factor. 
Concentration of Me supernatant (%)
Evidently MLC-SN does not competitively inhibit the action of Ly-5 antibody. In parallel tests with mc Lyb-2 antibody, to represent a system known to be concerned in early B cell activation and evidently not through the T cell interaction process, MLC-SN did not competitively inhibit the action of Lyb-2 antibody in reducing PFC generation either (Table VI) . RESPONSES OF MO-DEPLETED CELLS ASSISTED BY M~-SN (FIG. 5) . To test whether Ly-5 might be concerned in the process of B cell interaction with MqS, e.g., as a receptor for M4~ signals, the effect of Ly point. Fig. 5 shows that in fact there was a direct correlation between PFC generation in the presence of Ly-5 antibody (ordinate) and concentration of MqS-SN (abscissa). In contrast, PFC reduction by Lyb-2 antibody was not significantly affected by M~-SN through the same range of concentration. The following experiments confirm that Ly-5 is concerned in the interaction of B cells with M~. Purified B cells from B6-Lyb-2.1 congenic mice (Ly-5.1, Lyb-2.1) were cultured with a wide range of Mq~-SN (0.125-4%) in the presence of mc-a-Ly-5.1 or mc-a-Lyb-2.1 antibody. As a source of T helper factors, 15% MLC-SN was added 2 d later. As shown in Fig. 6 , Ly-5 antibody strongly inhibited PFC generation from B cells cultured with lower concentrations of MC-SN (0.125-0.5%), but this blocking effect was progressively abrogated at higher concentrations (2-4%). Thus the PFCreducing effect of Ly-5 antibody was reversed by overloading with M~a-SN in dosedependent fashion. In contrast, Lyb-2 antibody strongly inhibited PFC generation from B cells assisted by M~-SN irrespective of MqS-SN concentrations.
If Ly-5 is concerned in reception or operation of M~a factor, then PFC inhibition by Ly-5 antibody should be maximal when antibody is added at the time of action of Mdp factor, and this is so. When Mdp-SN was added to B cell cultures at the time of initiation, Ly-5 antibody was effective only when added at that time (Fig. 7, panel  A) . When addition of M¢-SN was delayed for 44 h, Ly-5 antibody was effective when added up to 44 h later, but not thereafter (panel B). The contrast with Lyb-2 is evident in panels A and B.
These results imply that Ly-5 mediates a B cell activation process that is distinct from the action of Lyb-2 and that Ly-5 antibody either reacts with a molecule of high affinity for helper factors present in M~b-SN but not for T helper factors present in MLC-SN, or affects this process by inactivating signals generated by the reaction of M~b signal with its receptor.
Discussion
These studies of the immune functional correlates of Ly-5 followed the lines that were adopted for previous study of Lyb-2. Unlike Lyb-2, expression of Ly-5 is not confined to B cells but occurs also in T cells, M~b, and other hematopoietic lineages. Nevertheless the only functions we have seen to be significantly affected by inclusion of Ly-5 antibody in assay of immune function in vitro are those associated with B cells. Since T cells and Mqb have functions other than immunological--T cells are concerned in erythropoiesis (22 24) , for example--Ly-5 on non-B cells might have nonimmunological functions that have not been studied.
In comparing the action of Lyb-2 and Ly-5 mc antibodies in immune functional assays, the points of factual similarity are that both inhibit the generation of PFC to TD antigen (SRBC) but not to TI-1 antigen {TNP-LPS and TNP-BA), and in neither case can this be attributed to suppression by direct action upon the B cell or indirect action through other cells. A critical distinction between the two systems is that Ly-5 antibody inhibits PFC generation to TI-2 antigen (TNP-F), whereas Lyb-2 antibody does not. The salient property of TNP-F in this connection is that with this antigen, like SRBC, the PFC response in vitro depends on T cells and M~p (18) (19) (20) (21) , in contrast to TI-1 antigen. On these grounds Ly-5 could be involved in reception or effects ofT cell or Mqb signals, or alternatively Ly-5 could be concerned in early B cell triggering to TD and TI-2 antigen. However, the former interpretation is strongly favored by the finding that M~ factor competitively inhibits the action of Ly-5 antibody in reducing PFC generation to SRBC, and that PFC inhibition by Ly-5 antibody appears to be inseparable from the time of action of Mq~ factor.
Summary
Generation of anti-sheep erythrocyte plaque-forming ceils (PFC) is greatly reduced in the presence of monoclonal Ly-5 alloantibody. Although Ly-5 is expressed in one of its molecular forms on T cells and macrophages (M4,) involved in this response, the only demonstrated action of Ly-5 antibody was on B cells. Evidence from elimination of Lyt-2 + cells, and from the responses of serial proportions of Ly-5.1 and Ly-5.2 cells and of Ly-5 heterozygous cells, signifies that PFC reduction cannot be ascribed to any known mechanism of suppression or to a direct suppressive action of Ly-5 antibody on B cells. A critical distinction of Ly-5 from Lyb-2 is that Ly-5 antibody reduces PFC generation to trinitrophenylated Ficoll, a thymus-independent type 2 antigen requiring T cells and M4~ for maximal PFC generation in vitro. A second distinction is that PFC reduction by Ly-5 antibody is strictly tied to the time of operation of M~ factor, whereas PFC reduction by Lyb-2 antibody relates to the time of B cell triggering by antigen. Accordingly, M4~ factor competitively and quantitatively inhibits the action of Ly-5 antibody in reducing PFC generation. It is likely that the Ly-5 system is concerned in the reception or handling of M4~ message by B cells.
